L'Hôtel-Dieu de Clermont-Ferrand est le site d'un ancien établissement hospitalier remontant au XVIIIᵉ siècle, situé dans la partie sud du centre historique de Clermont-Ferrand, en Auvergne, sur le rebord du « plateau central ». Le site a une superficie de 4,5 hectares.

During the past decade, Hotel Dieu conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hotel Dieu" #1 sponsor was "Celgene" with 1 trials, followed by "European Society for Blood and Marrow Transplantation" with 1 trials sponsored, "Hopital Antoine Beclere" with 1 trials sponsored, "Institut du Cancer de Montpellier - Val d'Aurelle" with 1 trials sponsored and "University Hospital, Lille" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hotel Dieu" #1 collaborator was "Celgene Corporation" with 1 trials as a collaborator and "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hotel Dieu" are "Esophageal Cancer" (1 trials), "Hepatectomy" (1 trials), "Leukemia, Lymphoblastic, Acute" (1 trials), "Lymphoma, Mantle-Cell" (1 trials) and "Mantle Cell Lymphoma" (1 trials). Many other conditions were trialed in "Hotel Dieu" in a lesser frequency.

Most popular intervention types in "Hotel Dieu" are "Drug" (3 trials), "Procedure" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chemo-radiotherapy" (1 trials), "Dasatinib" (1 trials), "Dexamethasone" (1 trials), "External Biliary duct stent in the bile duct by cystic way" (1 trials) and "High-Dose radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hotel Dieu" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hotel Dieu". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hotel Dieu, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hotel Dieu, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".